Clinical trials recruiting for Brain Metastasases
Phase breakdown
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| Adebelimab | 1 |
| Alpelisib + Pembrolizumab | 1 |
| Bevacizumab | 1 |
| Cisplatin or carboplatin | 1 |
| third-generation EGFR TKIs (Almonertinib/Furmonertinib/Osimertinib) | 1 |
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| Texas | 1 |
Top cities
Self-screener
Recruiting trials
- AI-guided Prognostication and Cranial Radiotherapy Optimization in EGFR-TKI-treated Non-small Cell Lung Cancer Patients With Baseline Brain Metastases
- Phase Ib Study of AlpeliSib With PEmbroLizumab in Patients With mEtastatic Breast caNcer or melanomA (SELENA)
- Study of Radiotherapy Combined With Cisplatin/Carboplatin, Adebrelimab and Bevacizumab in the Treatment of TNBC-BM.
Related conditions
Trials recruiting for Brain Metastasases often also study these conditions. Each links to its own recruiting-trial list.
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Brain Metastasases trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.